心力衰竭的全球流行病学
Muhammad Shahzeb Khan1, Izza Shahid2, Ahmed Bennis3
1Division of Cardiology, Duke University School of Medicine, Durham, NC, USA.
Nature reviews. Cardiology
|June 26, 2024
概括
全球心力衰竭 (HF) 患病率正在上升,特别是在年轻人和低收入国家,尽管高收入国家患病率稳定. 这种趋势需要有针对性的监测和资源配置,以有效地管理心力衰竭.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一种复杂的临床综合征,具有显著的发病率和死亡率.
- 肝炎的流行病学数据是动态的,受人口统计,治疗和医疗保健准入的影响.
- 虽然高收入国家的HF发病率稳定或下降,但全球范围内的患病率正在增加.
研究的目的:
- 审查心力衰竭负担的全球趋势,重点关注左心室喷射小部分谱的变化.
- 讨论基于人口的HF发病率和流行率的不断变化的估计.
- 为了检查风险因素,病因和HF的结果在不同的地理区域和人群.
主要方法:
- 审查当前关于心力衰竭的流行病学数据.
- 分析HF发病率,流行率和结果的全球趋势.
- 专注于HF在不同射出分数类别和地理区域的变化.
主要成果:
- 由于人口老龄化,风险因素,新型疗法和改善的生存率,HF患病率在全球范围内不断增加.
- 在年轻的成年人中观察到HF的增加和转向HF与保留射出分数的转变.
- 在低收入和中等收入国家,对于高压存在显著的数据差异,突出显示了监测需求.
结论:
- 随着心力衰竭的不断变化的流行病学格局,需要定期监测和量身定制的资源分配.
- 了解高频负担的地理差异对于全球卫生战略至关重要.
- 需要进一步的研究,以解决低收入和中等收入国家的数据缺口,以全面管理高频率.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.4K
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564